Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H16N6S2 |
Molecular Weight | 380.49 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N\C(SC1=CC=CC=C1N)=C(C#N)/C(C#N)=C(\N)SC2=C(N)C=CC=C2
InChI
InChIKey=DVEXZJFMOKTQEZ-JYFOCSDGSA-N
InChI=1S/C18H16N6S2/c19-9-11(17(23)25-15-7-3-1-5-13(15)21)12(10-20)18(24)26-16-8-4-2-6-14(16)22/h1-8H,21-24H2/b17-11+,18-12+
Molecular Formula | C18H16N6S2 |
Molecular Weight | 380.49 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
U0126 is a highly selective inhibitor of both MEK1 and MEK2, a type of MAPK/ERK kinase. The inhibitory effects of U0126 on MEK and ERK activation have been confirmed repeatedly, and treatments with U0126 have been shown to inhibit proliferation and migration of cancer cells in vivo and in vitro. U0126 has been widely used as an inhibitor for the Ras/Raf/MEK/ERK signaling pathway. U0126 treatments lead to cancer cell death, which agrees with the well-known role of the Ras/Raf/MEK/ERK pathway in supporting cell survival. U0126 enhances apoptosis in human breast cancer MCF-7 cells, acute myeloid leukemia, and PC12 cells.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells. | 2000 Aug 21 |
|
5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases. | 2000 May 9 |
|
Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. | 2001 Apr 27 |
|
Arylhydrocarbon receptor (AhR) is involved in negative regulation of adipose differentiation in 3T3-L1 cells: AhR inhibits adipose differentiation independently of dioxin. | 2001 Aug |
|
Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. | 2001 Dec |
|
15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. | 2001 Dec 28 |
|
Potentiation of cadmium-induced cytotoxicity by sulfur amino acid deprivation through activation of extracellular signal-regulated kinase1/2 (ERK1/2) in conjunction with p38 kinase or c-jun N-terminal kinase (JNK). Complete inhibition of the potentiated toxicity by U0126 an ERK1/2 and p38 kinase inhibitor. | 2001 Nov 15 |
|
Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. | 2001 Oct 1 |
|
Early growth-responsive-1-dependent manganese superoxide dismutase gene transcription mediated by platelet-derived growth factor. | 2001 Sep |
|
Nickel requires hypoxia-inducible factor-1 alpha, not redox signaling, to induce plasminogen activator inhibitor-1. | 2001 Sep |
|
Cadmium-induced DNA synthesis and cell proliferation in macrophages: the role of intracellular calcium and signal transduction mechanisms. | 2002 Apr |
|
Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils. | 2002 Jul 19 |
|
A novel pathway for nickel-induced interleukin-8 expression. | 2002 Jul 5 |
|
IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. | 2002 Jun |
|
Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport. | 2002 Jun 28 |
|
Inorganic lead activates the mitogen-activated protein kinase kinase-mitogen-activated protein kinase-p90(RSK) signaling pathway in human astrocytoma cells via a protein kinase C-dependent mechanism. | 2002 Mar |
|
Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes. | 2002 Nov 1 |
|
Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein. | 2002 Nov 15 |
|
Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. | 2002 Sep |
|
Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. | 2002 Sep 1 |
|
Induction of early growth response gene Egr2 by basic calcium phosphate crystals through a calcium-dependent protein kinase C-independent p44/42 mitogen-activated protein kinase pathway. | 2003 |
|
Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. | 2003 Apr 11 |
|
Phosphorylation of initiation factor 4E is resistant to SB203580 in cells expressing a drug-resistant mutant of stress-activated protein kinase 2a/p38. | 2003 Aug |
|
Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain. | 2003 Aug 19 |
|
Pretreatment with PKC inhibitor triggers TNF-alpha induced apoptosis in TNF-alpha-resistant B16 melanoma BL6 cells. | 2003 Dec 26 |
|
Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. | 2003 Feb 14 |
|
Fibroblast growth factor-10 upregulates Na,K-ATPase via the MAPK pathway. | 2003 Jun 19 |
|
AhR- and ERK-dependent pathways function synergistically to mediate 2,3,7,8-tetrachlorodibenzo-p-dioxin suppression of peroxisome proliferator-activated receptor-gamma1 expression and subsequent adipocyte differentiation. | 2003 May 15 |
|
ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. | 2003 Nov 10 |
|
MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. | 2004 |
|
Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. | 2004 Feb |
|
Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. | 2004 Jan 9 |
|
Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. | 2004 May 4 |
|
Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway. | 2004 Nov |
|
Plasticity in the entorhinal cortex suppresses memory for contextual fear. | 2004 Nov 10 |
|
Modulation of the transactivation function of nuclear factor-kappaB by lipopolysaccharide in RAW264.7 macrophages. | 2004 Oct |
|
Asbestos induces tissue factor in Beas-2B cells via PI3 kinase-PKC-mediated signaling. | 2004 Oct 8 |
|
Arsenite regulates Cystic Fibrosis Transmembrane Conductance Regulator and P-glycoprotein: evidence of pathway independence. | 2005 |
|
Effects of organochlorine insecticides on MAP kinase pathways in human HaCaT keratinocytes: key role of reactive oxygen species. | 2005 Aug |
|
Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. | 2005 Dec |
|
Mesangial cell apoptosis induced by stimulation of the adenosine A3 receptor: signaling and apoptotic events. | 2005 Jan |
|
The effect of a brominated flame retardant, tetrabromobisphenol-A, on free radical formation in human neutrophil granulocytes: the involvement of the MAP kinase pathway and protein kinase C. | 2005 Jan |
|
Investigating the neuroprotective mechanism of action of a CDK5 inhibitor by phosphoproteome analysis. | 2005 Jul 1 |
|
7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. | 2005 Jun |
|
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). | 2005 Jun 15 |
|
Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages. | 2005 May |
|
Decrease in cytosolic phospholipase A2alpha mRNA levels by reactive oxygen species via MAP kinase pathways in PC12 cells: effects of dopaminergic neurotoxins. | 2005 May |
|
Transcriptional profiling of gamma delta T cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands. | 2005 May 15 |
|
Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. | 2005 Oct 21 |
|
Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. | 2005 Sep-Oct |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:05:06 GMT 2023
by
admin
on
Sat Dec 16 09:05:06 GMT 2023
|
Record UNII |
8027P94HLL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2149
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
593217
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/17/1935
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3006531
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY | |||
|
8027P94HLL
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY | |||
|
109511-58-2
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
DTXSID4040470
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY | |||
|
SUB192758
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY | |||
|
100000177388
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY | |||
|
C1825
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY | |||
|
90693
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY | |||
|
U0126
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY | |||
|
218601-62-8
Created by
admin on Sat Dec 16 09:05:07 GMT 2023 , Edited by admin on Sat Dec 16 09:05:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |